These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
494 related items for PubMed ID: 33259334
21. Inhibition of miR-23a attenuates doxorubicin-induced mitochondria-dependent cardiomyocyte apoptosis by targeting the PGC-1α/Drp1 pathway. Du J, Hang P, Pan Y, Feng B, Zheng Y, Chen T, Zhao L, Du Z. Toxicol Appl Pharmacol; 2019 Apr 15; 369():73-81. PubMed ID: 30831132 [Abstract] [Full Text] [Related]
23. Protective effect of Boerhaavia diffusa L. against mitochondrial dysfunction in angiotensin II induced hypertrophy in H9c2 cardiomyoblast cells. Prathapan A, Vineetha VP, Raghu KG. PLoS One; 2014 Apr 15; 9(4):e96220. PubMed ID: 24788441 [Abstract] [Full Text] [Related]
25. Hydrogen sulfide pretreatment improves mitochondrial function in myocardial hypertrophy via a SIRT3-dependent manner. Meng G, Liu J, Liu S, Song Q, Liu L, Xie L, Han Y, Ji Y. Br J Pharmacol; 2018 Apr 15; 175(8):1126-1145. PubMed ID: 28503736 [Abstract] [Full Text] [Related]
27. Bone morphogenetic protein-4 mediates cardiac hypertrophy, apoptosis, and fibrosis in experimentally pathological cardiac hypertrophy. Sun B, Huo R, Sheng Y, Li Y, Xie X, Chen C, Liu HB, Li N, Li CB, Guo WT, Zhu JX, Yang BF, Dong DL. Hypertension; 2013 Feb 15; 61(2):352-60. PubMed ID: 23248151 [Abstract] [Full Text] [Related]
30. Puerarin ameliorated pressure overload-induced cardiac hypertrophy in ovariectomized rats through activation of the PPARα/PGC-1 pathway. Hou N, Huang Y, Cai SA, Yuan WC, Li LR, Liu XW, Zhao GJ, Qiu XX, Li AQ, Cheng CF, Liu SM, Chen XH, Cai DF, Xie JX, Chen MS, Luo CF. Acta Pharmacol Sin; 2021 Jan 15; 42(1):55-67. PubMed ID: 32504066 [Abstract] [Full Text] [Related]
31. Caloric restriction ameliorates angiotensin II-induced mitochondrial remodeling and cardiac hypertrophy. Finckenberg P, Eriksson O, Baumann M, Merasto S, Lalowski MM, Levijoki J, Haasio K, Kytö V, Muller DN, Luft FC, Oresic M, Mervaala E. Hypertension; 2012 Jan 15; 59(1):76-84. PubMed ID: 22068868 [Abstract] [Full Text] [Related]
32. GJA1-20k attenuates Ang II-induced pathological cardiac hypertrophy by regulating gap junction formation and mitochondrial function. Fu YL, Tao L, Peng FH, Zheng NZ, Lin Q, Cai SY, Wang Q. Acta Pharmacol Sin; 2021 Apr 15; 42(4):536-549. PubMed ID: 32620936 [Abstract] [Full Text] [Related]
33. MICU1 and MICU2 control mitochondrial calcium signaling in the mammalian heart. Hasan P, Berezhnaya E, Rodríguez-Prados M, Weaver D, Bekeova C, Cartes-Saavedra B, Birch E, Beyer AM, Santos JH, Seifert EL, Elrod JW, Hajnóczky G. Proc Natl Acad Sci U S A; 2024 Aug 27; 121(35):e2402491121. PubMed ID: 39163336 [Abstract] [Full Text] [Related]
38. Novel role of mitochondrial GTPases 1 in pathological cardiac hypertrophy. Xu D, Zhao Y, Weng X, Lu Y, Li W, Tang K, Chen W, Liu Z, Qi X, Zheng J, Fassett J, Zhang Y, Xu Y. J Mol Cell Cardiol; 2019 Mar 27; 128():105-116. PubMed ID: 30707992 [Abstract] [Full Text] [Related]
39. Mitochondrial reprogramming induced by CaMKIIδ mediates hypertrophy decompensation. Westenbrink BD, Ling H, Divakaruni AS, Gray CB, Zambon AC, Dalton ND, Peterson KL, Gu Y, Matkovich SJ, Murphy AN, Miyamoto S, Dorn GW, Heller Brown J. Circ Res; 2015 Feb 27; 116(5):e28-39. PubMed ID: 25605649 [Abstract] [Full Text] [Related]